Detalhe da pesquisa
1.
Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.
Ann Epidemiol
; 45: 24-31.e3, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32336655
2.
The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.
Ann Epidemiol
; 28(12): 841-849, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29983236
3.
Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.
Ann Epidemiol
; 28(12): 833-840, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30037634
4.
Two years of Truvada for pre-exposure prophylaxis utilization in the US.
J Int AIDS Soc
; 17(4 Suppl 3): 19730, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25397476